These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8905824)

  • 21. Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives.
    Béhé M; Becker W; Gotthardt M; Angerstein C; Behr TM
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1140-6. PubMed ID: 12768330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative biodistribution of indium- and yttrium-labeled B3 monoclonal antibody conjugated to either 2-(p-SCN-Bz)-6-methyl-DTPA (1B4M-DTPA) or 2-(p-SCN-Bz)-1,4,7,10-tetraazacyclododecane tetraacetic acid (2B-DOTA).
    Camera L; Kinuya S; Garmestani K; Brechbiel MW; Wu C; Pai LH; McMurry TJ; Gansow OA; Pastan I; Paik CH
    Eur J Nucl Med; 1994 Jul; 21(7):640-6. PubMed ID: 7957350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative evaluation of glutamate-sensitive radiopharmaceuticals: Technetium-99m-glutamic acid and technetium-99m-diethylenetriaminepentaacetic acid-bis(glutamate) conjugate for tumor imaging.
    Kakkar D; Tiwari AK; Chuttani K; Kaul A; Singh H; Mishra AK
    Cancer Biother Radiopharm; 2010 Dec; 25(6):645-55. PubMed ID: 21204758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linker effects on biological properties of 111In-labeled DTPA conjugates of a cyclic RGDfK dimer.
    Jia B; Liu Z; Shi J; Yu Z; Yang Z; Zhao H; He Z; Liu S; Wang F
    Bioconjug Chem; 2008 Jan; 19(1):201-10. PubMed ID: 18069778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer.
    Müller C; Schibli R; Krenning EP; de Jong M
    J Nucl Med; 2008 Apr; 49(4):623-9. PubMed ID: 18344429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
    de Visser M; Janssen PJ; Srinivasan A; Reubi JC; Waser B; Erion JL; Schmidt MA; Krenning EP; de Jong M
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1134-9. PubMed ID: 12768332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs.
    Hofland LJ; Lamberts SW; van Hagen PM; Reubi JC; Schaeffer J; Waaijers M; van Koetsveld PM; Srinivasan A; Krenning EP; Breeman WA
    J Nucl Med; 2003 Aug; 44(8):1315-21. PubMed ID: 12902423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225.
    Wen X; Wu QP; Ke S; Ellis L; Charnsangavej C; Delpassand AS; Wallace S; Li C
    J Nucl Med; 2001 Oct; 42(10):1530-7. PubMed ID: 11585869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vivo evaluation of indium-111-diethylenetriaminepentaacetic acid-labelling for determining the sites and rates of protein catabolism in mice.
    Mukai T; Arano Y; Nishida K; Sasaki H; Saji H; Nakamura J
    J Pharm Pharmacol; 1999 Jan; 51(1):15-20. PubMed ID: 10197412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.
    Breeman WA; Hofland LJ; van der Pluijm M; van Koetsveld PM; de Jong M; Setyono-Han B; Bakker WH; Kwekkeboom DJ; Visser TJ; Lamberts SW
    Eur J Nucl Med; 1994 Apr; 21(4):328-35. PubMed ID: 7911760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]Bz-DTPA-hEGF in normal mice.
    Tolmachev V; Orlova A; Wei Q; Bruskin A; Carlsson J; Gedda L
    Cancer Biother Radiopharm; 2004 Aug; 19(4):491-501. PubMed ID: 15453964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors.
    Tolmachev V; Nilsson FY; Widström C; Andersson K; Rosik D; Gedda L; Wennborg A; Orlova A
    J Nucl Med; 2006 May; 47(5):846-53. PubMed ID: 16644755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Krypton-81m ventilation and technetium-99m macroaggregated albumin perfusion scintigraphy for detection of pulmonary embolism: the first experience in Taiwan.
    Cherng SC; Yang SP; Wang YF; Jen TK; Huang WS; Lo AR
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Dec; 63(12):876-84. PubMed ID: 11195138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in biodistribution between 99mTc-depreotide, 111In-DTPA-octreotide, and 177Lu-DOTA-Tyr3-octreotate in a small cell lung cancer animal model.
    Schmitt A; Bernhardt P; Nilsson O; Ahlman H; Kölby L; Forssell-Aronsson E
    Cancer Biother Radiopharm; 2005 Apr; 20(2):231-6. PubMed ID: 15869461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, biodistribution, and estrogen receptor scintigraphy of indium-111-diethylenetriaminepentaacetic acid-tamoxifen analogue.
    Delpassand ES; Yang DJ; Wallace S; Cherif A; Quadri SM; Price J; Joubert A; Inoue T; Podoloff DA
    J Pharm Sci; 1996 Jun; 85(6):553-9. PubMed ID: 8773948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast-milk radioactivity after a Tc-99m DTPA aerosol/Tc-99m MAA lung study.
    Mountford PJ; Hall FM; Wells CP; Coakley AJ
    J Nucl Med; 1984 Oct; 25(10):1108-10. PubMed ID: 6384439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new technique for the preparation of ready-to-use macroaggregated albumin (MAA) kits to be labelled with 99mTc for lung scanning.
    Al-Janabi MA; Yousif ZM; Kadim AH; Al-Salem AM
    Int J Appl Radiat Isot; 1983 Oct; 34(10):1473-8. PubMed ID: 6227565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer.
    Reilly RM; Chen P; Wang J; Scollard D; Cameron R; Vallis KA
    J Nucl Med; 2006 Jun; 47(6):1023-31. PubMed ID: 16741313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tecnetium-99m as alternative to produce somatostatin-labeled derivatives: comparative biodistribution evaluation with 111In-DTPA-octreotide.
    Melo IB; Ueda LT; Araujo EB; Muramoto E; Barboz MF; Mengatti J; Buchpiguel CA; Silva CP
    Cell Mol Biol (Noisy-le-grand); 2010 May; 56(2):31-6. PubMed ID: 20525456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New chelating agent for attaching indium-111 to monoclonal antibodies: in vitro and in vivo evaluation.
    Subramanian R; Colony J; Shaban S; Sidrak H; Haspel MV; Pomato N; Hanna MG; McCabe RP
    Bioconjug Chem; 1992; 3(3):248-55. PubMed ID: 1520729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.